Literature DB >> 590992

Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis.

B Veress, A Omer, A A Satir, A M El Hassan.   

Abstract

Histological appearances of the spleen and lymph nodes were analysed in twenty fatal cases of human visceral leishmaniasis from Sudan. Marked atrophy of the splenic white pulp was associated with necrosis and fibrosis of thymus-dependent area, accumulation of parasite-containing histiocytes and plasma cell hyperplasia. Depletion of small lymphocytes in the paracortical areas of the lymph nodes was accomplained by proliferation of plasma cells and histiocytes in the paracortex. Depletion of small lymphocytes in thymus-dependent regions of lymph nodes and spleen is viewed as arising from immune suppression associated with antigen overloading or other factors, which may impair those aspects of lymphocyte-macrophage cooperation that are presumably necessary to kill the invading parasites.

Entities:  

Mesh:

Year:  1977        PMID: 590992      PMCID: PMC1445510     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Defect of macrophage function in the antibody response to sheep erythrocytes in systemic Mycobacterium lepraemurium infection.

Authors:  S R Watson; V S Sljivić; I N Brown
Journal:  Nature       Date:  1975-07-17       Impact factor: 49.962

2.  Immune complexes in the spleen. The difference between competitive inhibition of immune complex trapping in spleen follicles and inhibition by paratyphoid vaccine.

Authors:  N van Rooijen
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

3.  A relationship between impaired cellular immunity humoral suppression of lymphocyte function and severity of systemic lupus erythematosus.

Authors:  D A Horwitz; J B Cousar
Journal:  Am J Med       Date:  1975-06       Impact factor: 4.965

4.  The effect of prolonged treatment with antilymphocyte serum on the course of infections with BCG and Leishmania enriettii in the guinea-pig.

Authors:  A D Bryceson; J L Turk
Journal:  J Pathol       Date:  1971-07       Impact factor: 7.996

5.  Selective differentiation between amyloid and connective tissue structures based on the collagen specific topo-optical staining reaction with congo red.

Authors:  G Romhányi
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1971

6.  Immunological basis for depression of cellular immunity and the delayed allergic response in patients with lepromatous leprosy.

Authors:  J L Turk; M F Waters
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

7.  Experimental murine leprosy. 8. Ultrastructural features of the inflammatory exudate and bacterial morphology in C3H and C57BL mice after foot-pad inoculation with Mycobacterium lepraemurium.

Authors:  O A Haugen; F Skjorten; O Closs
Journal:  Acta Pathol Microbiol Scand A       Date:  1975-11

8.  Correlation of immunological function with splenic histopathology during the preclinical stages of host-versus-graft syndrome in parent-F1 mouse chimeral.

Authors:  R C Hard
Journal:  Transplantation       Date:  1974-06       Impact factor: 4.939

9.  New observations on the epidemiology and pathogenesis of sporotrichosis.

Authors:  T Carrada-Bravo
Journal:  Ann Trop Med Parasitol       Date:  1975-09

10.  The role of the macrophage in cutaneous leishmaniasis.

Authors:  F S Farah; S A Samra; N Nuwayri-Salti
Journal:  Immunology       Date:  1975-10       Impact factor: 7.397

View more
  33 in total

1.  Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation.

Authors:  Eszter Deak; Asha Jayakumar; Ka Wing Cho; Karen Goldsmith-Pestana; Blaise Dondji; John D Lambris; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

2.  Bone marrow parasite burden among patients with New World kala-azar is associated with disease severity.

Authors:  Joyce M Silva; Danielle A Zacarias; Lívio C de Figueirêdo; Maria Regiane A Soares; Edna A Y Ishikawa; Dorcas L Costa; Carlos H N Costa
Journal:  Am J Trop Med Hyg       Date:  2014-03-10       Impact factor: 2.345

3.  Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post-kala-azar dermal leishmaniasis.

Authors:  A K Ghosh; S Dasgupta; A C Ghose
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

4.  Cyclophosphamide affects the dynamics of granuloma formation in experimental visceral leishmaniasis.

Authors:  E B Corrêa; J M Cunha; M M Bunn-Moreno; E D Madeira
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

5.  Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends.

Authors:  Stanislaw Gorski; Simon M Collin; Koert Ritmeijer; Kees Keus; Francis Gatluak; Marius Mueller; Robert N Davidson
Journal:  PLoS Negl Trop Dis       Date:  2010-06-08

6.  Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis.

Authors:  J P Haldar; S Ghose; K C Saha; A C Ghose
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

7.  Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.

Authors:  E M Carvalho; R S Teixeira; W D Johnson
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

8.  Host-parasite relationship in murine leishmaniasis: pathophysiological and immunological changes.

Authors:  N E Reiner
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

9.  Studies on visceral Leishmania tropica infection in BALB/c mice. I. Clinical features and cellular changes.

Authors:  J Djoko-Tamnou; C Leclerc; F Modabber; L Chedid
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

10.  Weight reduction of thymus and depletion of lymphocytes of T-dependent areas in peripheral lymphoid tissues of mice infected with Francisella tularensis.

Authors:  M Ito; K Nishiyama; S Hyodo; S Shigeta; T Ito
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.